These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2370014)

  • 1. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.
    Brynskov J; Tvede N
    Gut; 1990 Jul; 31(7):795-9. PubMed ID: 2370014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.
    Crabtree JE; Juby LD; Heatley RV; Lobo AJ; Bullimore DW; Axon AT
    Gut; 1990 Sep; 31(9):1033-6. PubMed ID: 2210449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
    Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
    Simsek H; Kadayifci A
    J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
    Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.
    Van Kemseke C; Belaiche J; Louis E
    Int J Colorectal Dis; 2000 Aug; 15(4):206-10. PubMed ID: 11008719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations.
    Alexander AG; Barnes NC; Kay AB; Corrigan CJ
    Eur Respir J; 1995 Apr; 8(4):574-8. PubMed ID: 7664856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
    Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
    Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD; Rossi TM; Lebenthal E
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circulating common gamma chain (CD132) in inflammatory bowel disease.
    Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T
    Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor and disease activity in Crohn's disease.
    Williams AJ; Symons JA; Watchet K; Duff GW
    J Autoimmun; 1992 Apr; 5(2):251-9. PubMed ID: 1627235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptor as a marker of lymphocyte activation in childhood Crohn's disease.
    Proujansky R; Carpenter AB
    J Pediatr Gastroenterol Nutr; 1991 Oct; 13(3):277-84. PubMed ID: 1791504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum IL-2 and sIL-2R concentration in children with chronic hepatitis B].
    Pawłowska M; Halota W; Smukalska E; Grabczewska E
    Pol Merkur Lekarski; 2005 Jan; 18(103):33-5. PubMed ID: 15859543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].
    Wang Z; Li D; Yang J
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):439-41. PubMed ID: 9387297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
    Wang L; Wang JH; Liu WJ; Wang WD; Wang H; Chen XQ; Geng QR; Lu Y; Xia ZJ
    Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity.
    Alpsoy E; Cayirli C; Er H; Yilmaz E
    J Dermatol; 1998 Aug; 25(8):513-6. PubMed ID: 9769596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between the serum levels of interleukin-2 and soluble interleukin-2 receptor and the response to immunosuppressive therapy in severe aplastic anemia patients].
    Shao Z; Chen K; Chen G; Zhang Y; Wang T; Zou R; Zhou X; Zhou Y; Chu Y
    Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):180-2. PubMed ID: 15622762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
    Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
    Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity.
    Nancey S; Hamzaoui N; Moussata D; Graber I; Bienvenu J; Flourie B
    Dig Dis Sci; 2008 Jan; 53(1):242-7. PubMed ID: 17549633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.